review Open AccessTop 1% cited
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
The Lancet · 2010 · Vol. 376(9753) · pp. 1670–1681
C BaigentColin BaigentLisa BlackwellJonathan EmbersonL E HollandChristina ReithNeeraj BhalaR PetoElizabeth H BarnesAnthony KeechJohn Simes
Lipoproteins and Cardiovascular HealthCoronary Interventions and DiagnosticsAntiplatelet Therapy and Cardiovascular DiseasesMedicineStatinInternal medicineCholesterolMyocardial infarctionRandomized controlled trialClinical trial
MeSH terms
Coronary DiseaseHumansCholesterol, LDLMyocardial InfarctionRandomized Controlled Trials as TopicHydroxymethylglutaryl-CoA Reductase InhibitorsStroke
Funding
- British Heart Foundation
- University of Oxford
- Medical Research Council
- National Health and Medical Research Council
Citations
6,335
FWCI
267.81
field-weighted impact
References
55
Percentile
100%
vs. same field & year
Citations per year
Cited by
Stroke Risk Factors, Genetics, and Prevention
Circulation Research · 2017 · 1,866 citations
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Circulation · 2019 · 6,114 citations
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Circulation · 2019 · 4,494 citations
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
European Heart Journal · 2017 · 9,605 citations
Management of Acute Ischemic Stroke
Critical Care Medicine · 2020 · 866 citations
Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
The Journal of Clinical Endocrinology & Metabolism · 2012 · 1,439 citations
Macrophages in Atherosclerosis Regression
Arteriosclerosis Thrombosis and Vascular Biology · 2019 · 597 citations
Joint British Societies’ consensus recommendations for the prevention of cardiovascular disease (JBS3)
Heart · 2014 · 609 citations
References
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
The Lancet · 2002 · 6,993 citations
Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial
Diabetes Care · 1993 · 4,087 citations
Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease
Heart · 2008 · 551 citations
Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
Circulation · 2004 · 6,919 citations
Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels
JAMA · 1998 · 5,284 citations
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
New England Journal of Medicine · 2008 · 6,562 citations
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
New England Journal of Medicine · 1995 · 7,469 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.